RCC Laboratories India Private Limited Revenue and Competitors

Location

N/A

Total Funding

Consumer

Industry

Estimated Revenue & Valuation

  • RCC Laboratories India Private Limited's estimated annual revenue is currently $20.6M per year.(i)
  • RCC Laboratories India Private Limited's estimated revenue per employee is $251,000

Employee Data

  • RCC Laboratories India Private Limited has 82 Employees.(i)
  • RCC Laboratories India Private Limited grew their employee count by 1% last year.

RCC Laboratories India Private Limited's People

NameTitleEmail/Phone
1
Deputy Director & TFMReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$379M1056-3%$109.1MN/A
#2
$65.6M243-2%$122.3MN/A
#3
$630.3M175623%$28MN/A
#4
$1165.8M32482%$358.2MN/A
#5
$27.1M1082%$9.4MN/A
#6
$99.8M31333%$16MN/A
#7
$213.6M6703%$33.2MN/A
#8
$26.6M106-2%$8MN/A
#9
$15.6M6911%N/AN/A
#10
$7.8M410%$2.4MN/A
Add Company

What Is RCC Laboratories India Private Limited?

- RCC Laboratories India Private Limited is one of the leading contract research organizations providing preclinical and safety Toxicology & chemical testing globally. - We maintain high quality standards and services and remain a leader in Contract Research Services internationally. - RCC complies with the OECD principles of Good Laboratory Practice (GLP) and is Certified by GLP monitoring authority of the Government of India (NGCMA) - All studies are conducted at RCC in accordance with the regulatory requirements of the OECD, Schedule Y, EU, EPA, ICH, OPPTS, ISO etc.

keywords:N/A

N/A

Total Funding

82

Number of Employees

$20.6M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

RCC Laboratories India Private Limited News

2022-03-22 - Form 10-K Werewolf Therapeutics, For: Dec 31

Whereas many cancer treatments were historically limited to surgical ... Aldesleukin is approved for the treatment of metastatic RCC and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.5M8271%N/A
#2
$300M8226%N/A
#3
$11.9M82-1%$10M
#4
$8.4M82-6%N/A
#5
$27.4M8312%N/A